Osaka, Japan

Shuji Yonezawa

USPTO Granted Patents = 6 



Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Hokkaido, JP (2014)
  • Sapporo, JP (2017)
  • Osaka, JP (2012 - 2019)

Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Shuji Yonezawa: Innovator in Pharmaceutical Chemistry

Introduction

Shuji Yonezawa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on quinazoline derivatives. With a total of 6 patents to his name, Yonezawa continues to push the boundaries of scientific research and development.

Latest Patents

One of Yonezawa's latest patents involves the development of salts of quinazoline derivatives or crystals thereof. This invention provides a pharmaceutical composition that includes an acid addition salt of a compound represented by a specific formula. The process for producing these crystals is also detailed in the patent, showcasing Yonezawa's commitment to advancing pharmaceutical applications.

Career Highlights

Yonezawa is currently associated with Shionogi & Company Limited, a leading pharmaceutical company known for its innovative research and development. His work at Shionogi has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical science.

Collaborations

Some of Yonezawa's notable coworkers include Yuusuke Tamura and Yukio Tada. Their collaborative efforts have played a crucial role in the success of various projects and patents, demonstrating the importance of teamwork in scientific innovation.

Conclusion

Shuji Yonezawa's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…